Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Tiseo

Showing results (11-20 of 362) with videos related to

Pageof 37
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
First-line chemotherapy treatment of advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?Marcello Tiseo, Andrea Ardizzoni, Luca Boni
Annals of Translational Medicine|February 12, 2019
Upfront osimertinib in <i>EGFR</i>-mutated non-small cell lung cancer: is brain still a sanctuary?Alessandro Leonetti, Francesco Facchinetti, Marcello Tiseo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
ERCC1 and small cell lung cancerGiulio Rossi, Nazarena Nannini, Marcello Tiseo
Journal of Thoracic Disease|April 30, 2015
Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangementsFrancesco Gelsomino, Giulio Rossi, Marcello Tiseo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Second-line Treatment of Small Cell Lung Cancer: Is Platinum Sensitivity a Relevant Prognostic Factor?Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Translational Lung Cancer Research|February 3, 2017
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistanceRoberta Minari, Paola Bordi, Marcello Tiseo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Cancers|October 15, 2014
MET and Small-Cell Lung CancerFrancesco Gelsomino, Giulio Rossi, Marcello Tiseo
Cancers|September 19, 2020
Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized TrialsFrancesco Facchinetti, Massimo Di Maio, Marcello Tiseo
Translational Cancer Research|February 4, 2022
Anti-angiogenesis boosts chemo-immunotherapy in patients with <i>EGFR</i> mutations or baseline liver metastases: insights from IMpower150 studySara Elena Rebuzzi, Francesco Facchinetti, Marcello Tiseo
Pageof 37

Showing results (11-20 of 362) with videos related to

Sort By:
Pageof 37
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
First-line chemotherapy treatment of advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?Marcello Tiseo, Andrea Ardizzoni, Luca Boni
Annals of Translational Medicine|February 12, 2019
Upfront osimertinib in <i>EGFR</i>-mutated non-small cell lung cancer: is brain still a sanctuary?Alessandro Leonetti, Francesco Facchinetti, Marcello Tiseo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
ERCC1 and small cell lung cancerGiulio Rossi, Nazarena Nannini, Marcello Tiseo
Journal of Thoracic Disease|April 30, 2015
Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangementsFrancesco Gelsomino, Giulio Rossi, Marcello Tiseo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Second-line Treatment of Small Cell Lung Cancer: Is Platinum Sensitivity a Relevant Prognostic Factor?Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Translational Lung Cancer Research|February 3, 2017
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistanceRoberta Minari, Paola Bordi, Marcello Tiseo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?Marcello Tiseo, Luca Boni, Andrea Ardizzoni
Cancers|October 15, 2014
MET and Small-Cell Lung CancerFrancesco Gelsomino, Giulio Rossi, Marcello Tiseo
Cancers|September 19, 2020
Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized TrialsFrancesco Facchinetti, Massimo Di Maio, Marcello Tiseo
Translational Cancer Research|February 4, 2022
Anti-angiogenesis boosts chemo-immunotherapy in patients with <i>EGFR</i> mutations or baseline liver metastases: insights from IMpower150 studySara Elena Rebuzzi, Francesco Facchinetti, Marcello Tiseo
Pageof 37